Tang Capital Management’s KalVista Pharmaceuticals KALV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $55.9M | Hold |
4,941,798
| – | – | 2.82% | 7 |
|
|
2025
Q1 | $57M | Buy |
4,941,798
+47,951
| +1% | +$553K | 3.16% | 6 |
|
|
2024
Q4 | $41.5M | Buy |
4,893,847
+572,300
| +13% | +$4.85M | 2.74% | 8 |
|
|
2024
Q3 | $50M | Buy |
4,321,547
+102,718
| +2% | +$1.19M | 3.57% | 6 |
|
|
2024
Q2 | $49.7M | Buy |
4,218,829
+93,484
| +2% | +$1.1M | 5.06% | 3 |
|
|
2024
Q1 | $48.9M | Buy |
4,125,345
+685,000
| +20% | +$8.12M | 5.09% | 3 |
|
|
2023
Q4 | $42.1M | Hold |
3,440,345
| – | – | 3.89% | 4 |
|
|
2023
Q3 | $33.1M | Buy |
3,440,345
+788,952
| +30% | +$7.6M | 4.67% | 4 |
|
|
2023
Q2 | $23.9M | Hold |
2,651,393
| – | – | 3.51% | 7 |
|
|
2023
Q1 | $20.8M | Sell |
2,651,393
-545,053
| -17% | -$4.28M | 3.11% | 8 |
|
|
2022
Q4 | $21.6M | Buy |
3,196,446
+1,396,446
| +78% | +$9.44M | 3.14% | 10 |
|
|
2022
Q3 | $26.1M | Hold |
1,800,000
| – | – | 3.2% | 9 |
|
|
2022
Q2 | $17.7M | Buy |
1,800,000
+1,151,731
| +178% | +$11.3M | 2.69% | 11 |
|
|
2022
Q1 | $9.56M | Buy |
+648,269
| New | +$9.56M | 1.91% | 15 |
|